Literature DB >> 28238218

Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha-7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase.

A Kiss1,2, Y Tratsiakovich1, A Mahdi1, J Yang1, A T Gonon1, B K Podesser2, J Pernow1.   

Abstract

AIMS: Vagal nerve stimulation (VNS) protects from myocardial and vascular injury following myocardial ischaemia and reperfusion (IR) via a mechanism involving activation of alpha-7 nicotinic acetylcholine receptor (α7 nAChR) and reduced inflammation. Arginase is involved in development of myocardial IR injury driven by inflammatory mediators. The aim of the study was to clarify whether VNS downregulates myocardial and vascular arginase via a mechanism involving activation of α7 nAChR following myocardial IR.
METHODS: Anaesthetized rats were randomized to (i) sham-operated, (ii) control IR (30-min ischaemia and 2-h reperfusion, (iii) VNS throughout IR, (iv) the arginase inhibitor nor-NOHA+IR, (v) nor-NOHA+VNS+IR, (vi) selective α7 nAChR blockade by methyllycaconitine (MLA) followed by VNS throughout IR and (vii) MLA+IR.
RESULTS: Infarct size was reduced by VNS compared to control IR (41 ± 3% vs. 67 ± 2% of the myocardium at risk, P < 0.001). Myocardial IR increased myocardial and aortic arginase activity 1.7- and 3.1-fold respectively (P < 0.05). VNS attenuated the increase in arginase activity compared to control IR both in the myocardium and aorta (P < 0.05). MLA partially abolished the cardioprotective effect of VNS and completely abrogated the effect of VNS on arginase activity. Arginase inhibition combined with VNS did not further reduce infarct size.
CONCLUSION: Vagal nerve stimulation reduced infarct size and reversed the upregulation of arginase induced by IR both in the myocardium and aorta via a mechanism depending on α7 nAChR activation. The data suggest that the cardioprotective effect of VNS is mediated via reduction in arginase activity.
© 2017 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alpha-7 nicotinic acetylcholine receptor; arginase; ischaemia/reperfusion; vagal nerve stimulation

Mesh:

Substances:

Year:  2017        PMID: 28238218     DOI: 10.1111/apha.12861

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  10 in total

1.  Cholinergic receptors play a role in the cardioprotective effects of anesthetic preconditioning: Roles of nitric oxide and the CaMKKβ/AMPK pathway.

Authors:  Yang Yang; Ying Li; Jie Wang; Lei Hong; Shigang Qiao; Chen Wang; Jianzhong An
Journal:  Exp Ther Med       Date:  2020-12-14       Impact factor: 2.447

2.  Chronic vagal nerve stimulation exerts additional beneficial effects on the beta-blocker-treated failing heart.

Authors:  Meihua Li; Can Zheng; Toru Kawada; Masashi Inagaki; Kazunori Uemura; Masaru Sugimachi
Journal:  J Physiol Sci       Date:  2018-11-09       Impact factor: 2.781

Review 3.  Mediation of Cardiac Macrophage Activity via Auricular Vagal Nerve Stimulation Ameliorates Cardiac Ischemia/Reperfusion Injury.

Authors:  Chee Hooi Chung; Beatrice Bretherton; Satirah Zainalabidin; Susan A Deuchars; Jim Deuchars; Mohd Kaisan Mahadi
Journal:  Front Neurosci       Date:  2020-09-08       Impact factor: 4.677

4.  Vagus nerve stimulation in pregnant rats and effects on inflammatory markers in the brainstem of neonates.

Authors:  Allison Judkins; Rhaya L Johnson; Samuel T Murray; Steven M Yellon; Christopher G Wilson
Journal:  Pediatr Res       Date:  2017-11-22       Impact factor: 3.756

Review 5.  Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.

Authors:  Kannaporn Intachai; Siriporn C Chattipakorn; Nipon Chattipakorn; Krekwit Shinlapawittayatorn
Journal:  Int J Mol Sci       Date:  2018-08-21       Impact factor: 5.923

Review 6.  Current Directions in the Auricular Vagus Nerve Stimulation I - A Physiological Perspective.

Authors:  Eugenijus Kaniusas; Stefan Kampusch; Marc Tittgemeyer; Fivos Panetsos; Raquel Fernandez Gines; Michele Papa; Attila Kiss; Bruno Podesser; Antonino Mario Cassara; Emmeric Tanghe; Amine Mohammed Samoudi; Thomas Tarnaud; Wout Joseph; Vaidotas Marozas; Arunas Lukosevicius; Niko Ištuk; Antonio Šarolić; Sarah Lechner; Wlodzimierz Klonowski; Giedrius Varoneckas; Jozsef Constantin Széles
Journal:  Front Neurosci       Date:  2019-08-09       Impact factor: 4.677

Review 7.  Implant-Mediated Therapy of Arterial Hypertension.

Authors:  Mortimer Gierthmuehlen; Dennis T T Plachta; Josef Zentner
Journal:  Curr Hypertens Rep       Date:  2020-02-06       Impact factor: 5.369

8.  Tropisetron Preconditioning Decreases Myocardial Biomarkers in Patients Undergoing Heart Valve Replacement Surgery.

Authors:  Di Yu; Xingrui Gong; Yufei Zhang; Qing Li; Mazhang Zhang
Journal:  Front Med (Lausanne)       Date:  2022-03-29

Review 9.  Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases.

Authors:  Zhuozhuo Li; Liwei Wang; Yuanyuan Ren; Yaoyao Huang; Wenxuan Liu; Ziwei Lv; Lu Qian; Yi Yu; Yuyan Xiong
Journal:  Cell Death Discov       Date:  2022-10-08

10.  Nicotine Causes Nephrotoxicity through the Induction of NLRP6 Inflammasome and Alpha7 Nicotinic Acetylcholine Receptor.

Authors:  Cai-Mei Zheng; Yu-Hsuan Lee; I-Jen Chiu; Yu-Jhe Chiu; Li-Chin Sung; Yung-Ho Hsu; Hui-Wen Chiu
Journal:  Toxics       Date:  2020-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.